Is ABBOTT LABORATORIES (ABT) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 7.3% / 30% | 4.7% / 30% | 5.6% / 30% | 0.69% / 5% | ✓ HALAL |
| DJIM | 7.3% / 33% | 4.7% / 33% | 5.6% / 33% | 0.69% / 5% | ✓ HALAL |
| MSCI | 16.0% / 33% | 10.3% / 33% | 12.2% / 33% | 0.69% / 5% | ✓ HALAL |
| S&P | 7.3% / 33% | 4.7% / 33% | 5.6% / 33% | 0.69% / 5% | ✓ HALAL |
| FTSE | 16.0% / 33% | 10.3% / 33% | 12.2% / 50% | 0.69% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 56.7% | |
| Operating Margin | 21.6% | |
| Net Margin | 14.7% | |
| Return on Equity (ROE) | 13.0% | |
| Return on Assets (ROA) | 6.6% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $9.6B |
| Free Cash Flow | $7.4B |
| Total Debt | $13.9B |
| Debt-to-Equity | 26.8 |
| Current Ratio | 1.6 |
| Total Assets | $86.7B |
Price & Trading
| Last Close | $104.57 |
| 50-Day MA | $111.03 |
| 200-Day MA | $124.95 |
| Avg Volume | 11.0M |
| Beta | 0.7 |
|
52-Week Range
$102.41
| |
About ABBOTT LABORATORIES (ABT)
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. The company also provides cancer screening and diagnostic test products. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
Purification Calculator
As a halal stock with 0.69% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is ABBOTT LABORATORIES (ABT) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), ABBOTT LABORATORIES is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is ABBOTT LABORATORIES's debt ratio?
ABBOTT LABORATORIES's debt ratio is 7.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 16.0%.
Does ABBOTT LABORATORIES require dividend purification?
Yes, ABBOTT LABORATORIES has an impermissible income ratio of 0.69%, which means 0.69% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are ABBOTT LABORATORIES's key financial metrics?
ABBOTT LABORATORIES has a market capitalization of $180.7B, trailing P/E ratio of 28.0, and revenue of $44.3B. The company maintains a gross margin of 56.7% and a net margin of 14.7%. Return on equity stands at 13.0%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.